Top compounds associated with response to ACSF2


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.051 0.3
mRNA tivozanib GDSC1000 pan-cancer AAC -0.045 0.2
mRNA tivozanib CTRPv2 pan-cancer AAC -0.031 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC -0.039 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.12 9e-05
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.028 0.5
mRNA triptolide CTRPv2 pan-cancer AAC -0.066 0.07
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.055 0.3
Download CSV